(ANSA) - BRUSSELS, NOVEMBER 30 - If to face Omicron "we had to adapt the vaccines" we are in a position to approve them "in three to four months".
But first it is necessary to establish "if adaptation is needed", and, in the meantime, it is important to undergo the calls.
This was stated by the executive director of EMA, EmerCooke, in her reply to the European Parliament.
"From the data we see" on Omicron, "licensed vaccines are effective and continue to save people from severe disease and death. Even as the new variant spreads more, the vaccines we have will continue to provide protection." In front of the Omicron variant - she added - "we must work even harder than in the past to increase the rate of evaccinations in the EU, especially in Member States where the rate is dangerously low. This is particularly important as we learn new aspects of" Omicron ", said the director. executive of the EMA.
"We are still carefully evaluating", but if necessary, due to the new Omicron variant "we have emergency plans. We are ready for the worst even if we hope for the best.Vaccines remain the key tool ". (ANSA).
